Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Options for reducing uncertainty in impact classification for alien species

Autor: Clarke, DA, Palmer, DJ, McGrannachan, C, Burgess, TI, Chown, SL, Clarke, RH, Kumschick, S, Lach, L, Liebhold, AM, Roy, HE, Saunders, ME, Yeates, DK, Zalucki, MP, McGeoch, Melodie

Impact assessment is an important and cost-effective tool for assisting in the identification and prioritization of invasive alien species. With the number of alien and invasive alien species expected to increase, reliance on impact assessment tools

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a38bbfc16734ba5a37fc971f4a2cdd89

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tumor-specific cholinergic CD4 ⁺ T lymphocytes guide immunosurveillance of hepatocellular carcinoma.

Autor: Zheng C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China., Snow BE; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Elia AJ; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Nechanitzky R; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Dominguez-Brauer C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Liu S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Tong Y; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China.; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China., Cox MA; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Focaccia E; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Wakeham AC; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Haight J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Tobin C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Hodgson K; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Gill KT; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ma W; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Berger T; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; The M3 Research Center, Medical Faculty Tübingen, Tübingen, Germany., Saunders ME; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Fortin J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Leung SY; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China.; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China., Mak TW; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. tak.mak@uhnresearch.ca.; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China. tak.mak@uhnresearch.ca.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. tak.mak@uhnresearch.ca.; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China. tak.mak@uhnresearch.ca.; Departments of Immunology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. tak.mak@uhnresearch.ca.

Publikováno v: Nature cancer [Nat Cancer] 2023 Oct; Vol. 4 (10), pp. 1437-1454. Date of Electronic Publication: 2023 Aug 28.

A retrospective comparison of the emergent use of fixed-dose four-factor prothrombin complex versus weight-based dosing for intracranial hemorrhage assessing medication delivery time and cost.

Autor: Riha GM; Trauma & General Surgery, Billings Clinic Billings, MT, USA., Englehart MS; Trauma & General Surgery, Billings Clinic Billings, MT, USA., Walton KZ; Pharmacy, Billings Clinic Billings, MT, USA., Saunders ME; Pharmacy Informatics, Billings Clinic Billings, MT, USA., Carter BT; Collaborative Science & Innovation, Billings Clinic Billings, MT, USA., Thompson SJ; Collaborative Science & Innovation, Billings Clinic Billings, MT, USA.

Publikováno v: International journal of physiology, pathophysiology and pharmacology [Int J Physiol Pathophysiol Pharmacol] 2023 Jun 15; Vol. 15 (3), pp. 98-104. Date of Electronic Publication: 2023 Jun 15 (Print Publication: 2023).